The present work describes a validated reverse phase high performance liquid chromatographic method for estimation of Clopidogrel in the drug substances and dosage form. The quantification was carried out using Ultron ES OVM (150*4.6) mm, 5µm and mobile phase comprised of Buffer, Acetonitrile and in proportion of 70:30 %v/v. The flow rate was 1.0 ml/min and the eluent was monitored at 220 nm. The selected chromatographic conditions were found to effectively quantitate Clopidogrel at retention time of about 3.8 min. Linearity were found to be in the range of 11-75 μg/ml. The percentage recoveries of all the drugs were found to be 99.3-101.1%. The proposed method was found to be fast, specific, accurate, precise, and reproducible and can be used for estimation of the Clopidogrel drugs. 
INTRODUCTION
Clopidogrel is a prodrug, the action of which may be related to an adenosine diphosphate (ADP) receptor on platelet cell membranes. The drug specifically and irreversibly inhibits the P2Y subtype of ADP receptor, which is important in aggregation of platelets and crosslinking by the protein fibrin. Absorption and Distribution: It is rapidly absorbed after oral administration of repeated doses of 75 mg Clopidogrel, with peak plasma levels of the main circulating metabolite occurring approximately one hour after dosing. Absorption is at least 50% based on urinary excretion of Clopidogrel related metabolites.Clopidogrel undergoes rapid hydrolysis into its carboxylic acid derivative. In plasma and urine, the glucuronide of the carboxylic acid derivative is also observed.
MATERIALS AND METHODS

Reagents and Chemicals:
Clopidogrel drug sample, acetonitrile solvent of HPLC grade, potassium di-hydrogen phosphate, water of HPLC grade.
Instruments and Chromatographic Conditions:
HPLC system with UV/PDA detector was used for method development and validation. The separation were achieved on Ultron ES OVM (150*4.6) mm, 5µm column. The column was maintained at room temperature and the eluent was monitored at 220 nm using UV detector. The mixture of Potassium dihydrogen phosphate buffer 20mM (pH 4.2): Acetonitrile 70:30v/v at a flow rate of 1.0 ml/min was used as a mobile phase. The injection volume was 20μl.
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Preparation of Mobile phase:
Potassium di-hydrogen phosphate buffer 20 mM (pH 4.2): Acetonitrile in the ratio of 70:30 v/v.
Preparation of diluent
Mixed Methanol and water in ratio of 90:10 (v/v)
Preparation of standard solution
Weighed about 75 mg of Clopidogrel standard into 50 mL volumetric flask. Added 30 mL of diluent, sonicated to dissolve and made up volume with diluent and mixed well. Further, 5 ml of above solution dilute to 200 ml with diluent.
Preparation of sample solution
Weighed 20 tablets to find out average weight and crushed in to mortal pestle. Weighed the crushed sample equivalent to 375 mg of Clopidogrel and transferred in to 500 ml of volumetric flask. Added about 400 ml of diluent and sonicated for 60 minutes than made up volume with diluent and mixed well. Further, 5 ml of above solution dilute to 100 ml with diluent. 
Specificity
There are no any interference or peak observed from blank and placebo chromatogram at the retention time of Clopidogrel peak
Method precision
The % RSD for % assay of six replicate sample preparation were found to be 0.5 % which is within the acceptance criteria of 2.0% 
Accuracy
Accuracy were performed on 11 µg/ml (30%), 37.5 µg/ml (100%) and 75 µg/ml (200%). The mean % recovery found to be as below table.
